ALX Oncology Holdings Inc.
ALXOHealthcare|Biotechnology|US
$1.16
+0.01 (+0.43%)
DCF Value
$0.13
Tangible Book / Share
$1.00
Cash / Share
$1.02
Ownership Breakdown
68.7%
Float
138.3M
Shares Outstanding
95.0M
Float Shares
Major Holders (39)
Combined: 160.5%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Goodman Corey S | HC, IN | 9.99% | 12,927,442 | Oct 16, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 9.90% | 13,117,106 | Feb 9, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 9.90% | 13,117,106 | Feb 9, 2026 | 13D/G |
| Rajeev Shah | HC, IN | 9.90% | 13,117,106 | Feb 9, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 9.90% | 13,117,106 | Feb 9, 2026 | 13D/G |
| Adelman Robert J | Individual | 9.90% | 12,984,044 | Feb 4, 2026 | 13D/G |
| Redmile Group, LLC | IA, OO | 6.80% | 9,214,188 | May 15, 2026 | 13D/G |
| Jeremy C. Green | HC, IN | 6.80% | 9,214,188 | May 15, 2026 | 13D/G |
| venBio Global Strategic GP II, Ltd. | Corporation | 6.50% | 8,453,038 | Oct 16, 2026 | 13D/G |
| venBio Global Strategic Fund II L.P. | Partnership | 6.50% | 8,453,038 | Oct 16, 2026 | 13D/G |
| venBio Global Strategic GP II, L.P. | Partnership | 6.50% | 8,453,038 | Oct 16, 2026 | 13D/G |
| HBM Healthcare Investments (Cayman) Ltd. | Corporation | 6.50% | 8,590,692 | May 15, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.40% | 7,327,850 | Jul 27, 2026 | 13D/G |
| Chen Yu | Individual | 4.20% | 5,655,487 | Aug 14, 2026 | 13D/G |
| Redmile Biopharma Investments III, L.P. | Partnership | 3.90% | 5,267,838 | May 15, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 3.40% | 1,798,875 | Dec 6, 2024 | 13D/G |
| FMR LLC | Holding company | 3.40% | 1,798,875 | Dec 6, 2024 | 13D/G |
| Vivo Capital IX, LLC | Other | 3.40% | 1,813,864 | Nov 14, 2024 | 13D/G |
| Vivo Capital Fund IX, L.P. | Partnership | 3.40% | 1,813,864 | Nov 14, 2024 | 13D/G |
| venBio Global Strategic Fund, L.P. | Partnership | 3.30% | 4,307,034 | Oct 16, 2026 | 13D/G |
| venBio Global Strategic GP, L.P. | Partnership | 3.30% | 4,307,034 | Oct 16, 2026 | 13D/G |
| venBio Global Strategic GP, Ltd. | Corporation | 3.30% | 4,307,034 | Oct 16, 2026 | 13D/G |
| Michael A Carusi | Individual | 2.20% | 2,942,525 | May 27, 2026 | 13D/G |
| Henry A. Plain Jr | Individual | 2.20% | 2,942,525 | May 27, 2026 | 13D/G |
| Jean George | Individual | 2.20% | 2,942,525 | May 27, 2026 | 13D/G |
| TCG Crossover GP III, LLC | Other | 2.10% | 2,827,748 | Aug 14, 2026 | 13D/G |
| TCG Crossover Fund III, L.P. | Partnership | 2.10% | 2,827,748 | Aug 14, 2026 | 13D/G |
| TCG Crossover GP II, LLC | Other | 2.10% | 2,827,739 | Aug 14, 2026 | 13D/G |
| TCG Crossover Fund II, L.P. | Partnership | 2.10% | 2,827,739 | Aug 14, 2026 | 13D/G |
| Israel A. Englander | Individual | 1.50% | 1,988,559 | Apr 28, 2026 | 13D/G |
| Millennium Management LLC | Other | 1.50% | 1,988,559 | Apr 28, 2026 | 13D/G |
| Millennium Group Management LLC | Other | 1.50% | 1,988,559 | Apr 28, 2026 | 13D/G |
| LSV Associates, LLC | Other | 1.20% | 1,549,132 | May 27, 2026 | 13D/G |
| Lightstone Ventures, L.P. | Partnership | 1.00% | 1,363,262 | May 27, 2026 | 13D/G |
| LSV Associates II, LLC | Other | 1.00% | 1,393,393 | May 27, 2026 | 13D/G |
| Lightstone Ventures II, L.P. | Partnership | 1.00% | 1,315,255 | May 27, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 0.50% | 730,528 | Apr 28, 2026 | 13D/G |
| Lightstone Ventures (A), L.P. | Partnership | 0.10% | 185,870 | May 27, 2026 | 13D/G |
| Lightstone Ventures II (A), L.P. | Partnership | 0.10% | 78,138 | May 27, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 7,316,496 acquired · 24,112 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Aug 17, 2026 | SELL | 2,230 | $1.93 | $4.3K | Form 4 |
| Wong Shelly | SVP, FINANCE AND CAO | Aug 17, 2026 | SELL | 573 | $1.93 | $1.1K | Form 4 |
| Wong Shelly | SVP, FINANCE AND CAO | Jul 1, 2026 | SELL | 1,404 | $2.04 | $2.9K | Form 4 |
| Knight Jeff E. | Chief Dev & Operating Officer | Apr 16, 2026 | AWARD | 800,000 | $1.68 | $1.3M | Form 4 |
| Klencke Barbara | Chief Medical Officer | Apr 16, 2026 | AWARD | 100,000 | $1.68 | $168.0K | Form 4 |
| Knight Jeff E. | Apr 13, 2026 | OTHER | 0 | — | — | Form 4 | |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Mar 19, 2026 | SELL | 12,311 | $2.17 | $26.7K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Mar 19, 2026 | SELL | 903 | $2.17 | $2.0K | Form 4 |
| Klencke Barbara | Chief Medical Officer | Mar 3, 2026 | AWARD | 700,000 | $2.07 | $1.4M | Form 4 |
| Klencke Barbara | Chief Medical Officer | Feb 25, 2026 | OTHER | 0 | — | — | Form 4 |
| Klencke Barbara | Chief Medical Officer | Feb 25, 2026 | OTHER | 40,400 | $1.65 | $66.7K | Form 4 |
| Klencke Barbara | Chief Medical Officer | Feb 25, 2026 | OTHER | 300,000 | $1.05 | $315.0K | Form 4 |
| Klencke Barbara | Chief Medical Officer | Feb 25, 2026 | OTHER | 100,000 | $1.48 | $148.0K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Feb 18, 2026 | SELL | 565 | $2.27 | $1.3K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Feb 17, 2026 | TAX W/H | 2,201 | $2.27 | $5.0K | Form 4 |
| GOODMAN COREY S | director, 10 percent owner: | Feb 2, 2026 | BUY | 3,184,713 | $1.57 | $5.0M | Form 4 |
| Shantharam Harish | Chief Financial Officer | Jan 26, 2026 | AWARD | 303,000 | $1.48 | $448.4K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Jan 26, 2026 | AWARD | 192,000 | $1.48 | $284.2K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Jan 26, 2026 | AWARD | 912,000 | $1.48 | $1.3M | Form 4 |
| GOODMAN COREY S | director, 10 percent owner: | Jan 20, 2026 | AWARD | 40,400 | $1.32 | $53.3K | Form 4 |
| Garland J. Scott | director | Jan 20, 2026 | AWARD | 40,400 | $1.32 | $53.3K | Form 4 |
| Sandler Alan B. | director | Jan 20, 2026 | AWARD | 10,100 | $1.32 | $13.3K | Form 4 |
| Curran Daniel J. | director | Jan 20, 2026 | AWARD | 16,833 | $1.32 | $22.2K | Form 4 |
| Takimoto Chris H | director | Jan 20, 2026 | AWARD | 40,400 | $1.32 | $53.3K | Form 4 |
| Hemrajani Rekha | director | Jan 20, 2026 | AWARD | 40,400 | $1.32 | $53.3K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Jan 6, 2026 | SELL | 3,925 | $1.11 | $4.4K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Oct 14, 2025 | AWARD | 140,000 | $1.70 | $238.0K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Oct 14, 2025 | AWARD | 597,500 | $1.70 | $1.0M | Form 4 |
| Shantharam Harish | Chief Financial Officer | Oct 14, 2025 | AWARD | 198,750 | $1.70 | $337.9K | Form 4 |
| Klencke Barbara | director | Sep 17, 2025 | AWARD | 300,000 | $1.05 | $315.0K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Sep 17, 2025 | BUY | 71,163 | $1.08 | $76.9K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Sep 16, 2025 | BUY | 21,070 | $1.07 | $22.5K | Form 4 |
| Shantharam Harish | Chief Financial Officer | Aug 18, 2025 | BUY | 75,000 | $0.78 | $58.4K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Aug 15, 2025 | SELL | 611 | $0.64 | $391.28 | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Aug 15, 2025 | SELL | 2,382 | $0.64 | $1.5K | Form 4 |
| Curran Daniel J. | director | Aug 12, 2025 | AWARD | 40,400 | $0.61 | $24.8K | Form 4 |
| Curran Daniel J. | Aug 12, 2025 | OTHER | 0 | — | — | Form 4 | |
| Pinto Shelly | SVP, FINANCE AND CAO | Jul 7, 2025 | SELL | 2,011 | $0.45 | $905.15 | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Jun 30, 2025 | SELL | 1,532 | $0.43 | $658.76 | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Apr 11, 2025 | AWARD | 90,000 | $0.49 | $44.1K | Form 4 |
| Sandler Alan B. | Chief Medical Officer | Apr 11, 2025 | AWARD | 125,000 | $0.49 | $61.3K | Form 4 |
| Shantharam Harish | Chief Financial Officer | Apr 11, 2025 | AWARD | 125,000 | $0.49 | $61.3K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Apr 11, 2025 | AWARD | 125,000 | $0.49 | $61.3K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Mar 14, 2025 | AWARD | 3,000 | — | — | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Mar 14, 2025 | AWARD | 42,000 | — | — | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Feb 19, 2025 | SELL | 550 | $1.15 | $632.61 | Form 4 |
| Pons Jaume | PRESIDENT & CSO | Feb 19, 2025 | SELL | 1,326 | $1.15 | $1.5K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Feb 19, 2025 | SELL | 2,159 | $1.15 | $2.5K | Form 4 |
| Hemrajani Rekha | director | Jan 21, 2025 | AWARD | 40,400 | $1.65 | $66.7K | Form 4 |
| Garland J. Scott | director | Jan 21, 2025 | AWARD | 40,400 | $1.65 | $66.7K | Form 4 |
| GOODMAN COREY S | director, 10 percent owner: | Jan 21, 2025 | AWARD | 40,400 | $1.65 | $66.7K | Form 4 |
| Takimoto Chris H | director | Jan 21, 2025 | AWARD | 40,400 | $1.65 | $66.7K | Form 4 |
| Takimoto Chris H | Jan 21, 2025 | OTHER | 0 | — | — | Form 4 | |
| Klencke Barbara | director | Jan 21, 2025 | AWARD | 40,400 | $1.65 | $66.7K | Form 4 |
| Klencke Barbara | director | Jan 21, 2025 | OTHER | 0 | — | — | Form 4 |
| Shantharam Harish | Chief Financial Officer | Jan 21, 2025 | AWARD | 600,000 | $1.65 | $990.0K | Form 4 |
| Shantharam Harish | Jan 21, 2025 | OTHER | 0 | — | — | Form 4 | |
| Pinto Shelly | SVP, FINANCE AND CAO | Jan 21, 2025 | AWARD | 112,000 | $1.65 | $184.8K | Form 4 |
| Sandler Alan B. | Chief Medical Officer | Jan 21, 2025 | AWARD | 100,000 | $1.65 | $165.0K | Form 4 |
| Pons Jaume | PRESIDENT & CSO | Jan 21, 2025 | AWARD | 50,000 | $1.65 | $82.5K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Jan 21, 2025 | AWARD | 478,000 | $1.65 | $788.7K | Form 4 |
| Pinto Shelly | Interim CFO | Jan 6, 2025 | SELL | 2,221 | $1.80 | $4.0K | Form 4 |
| Pinto Shelly | Interim CFO | Dec 30, 2024 | SELL | 1,426 | $1.58 | $2.3K | Form 4 |
| Pons Jaume | PRESIDENT & CSO | Dec 30, 2024 | SELL | 10,796 | $1.58 | $17.1K | Form 4 |
| Hemrajani Rekha | director | Dec 2, 2024 | BUY | 30,000 | $1.55 | $46.4K | Form 4 |
| Pinto Shelly | Interim CFO | Dec 2, 2024 | AWARD | 150,000 | $1.66 | $249.0K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Dec 2, 2024 | AWARD | 200,000 | $1.66 | $332.0K | Form 4 |
| Sandler Alan B. | Chief Medical Officer | Nov 18, 2024 | AWARD | 600,000 | $1.22 | $732.0K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Aug 14, 2024 | SELL | 564 | $2.58 | $1.5K | Form 4 |
| Randolph Sophia | CHIEF MEDICAL OFFICER | Aug 14, 2024 | SELL | 1,365 | $2.58 | $3.5K | Form 4 |
| GARCIA PETER S | CHIEF FINANCIAL OFFICER | Aug 14, 2024 | TAX W/H | 761 | $2.58 | $2.0K | Form 4 |
| Pons Jaume | PRESIDENT & CSO | Aug 14, 2024 | SELL | 1,937 | $2.58 | $5.0K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Aug 14, 2024 | TAX W/H | 2,191 | $2.58 | $5.7K | Form 4 |
| Sandler Alan B. | director | Aug 5, 2024 | AWARD | 40,400 | $2.73 | $110.3K | Form 4 |
| Sandler Alan B. | Aug 5, 2024 | OTHER | 0 | — | — | Form 4 | |
| Pons Jaume | director, officer: PRESIDENT & CSO | Jul 11, 2024 | OPTION EX. | 20,000 | $0.99 | $19.8K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Jul 11, 2024 | SELL | 20,000 | $7.90 | $158.1K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Jul 11, 2024 | OPTION EX. | 20,000 | $0.99 | $19.8K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Jul 5, 2024 | SELL | 1,823 | $5.50 | $10.0K | Form 4 |
| Pinto Shelly | SVP, FINANCE AND CAO | Jul 1, 2024 | SELL | 1,373 | $5.82 | $8.0K | Form 4 |
| Randolph Sophia | director, officer: CHIEF MEDICAL OFFICER | Jul 1, 2024 | SELL | 3,273 | $5.82 | $19.0K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Jul 1, 2024 | SELL | 10,758 | $5.82 | $62.6K | Form 4 |
| GARCIA PETER S | CHIEF FINANCIAL OFFICER | Jun 28, 2024 | TAX W/H | 1,789 | $6.03 | $10.8K | Form 4 |
| GARCIA PETER S | CHIEF FINANCIAL OFFICER | Jun 13, 2024 | BUY | 12,000 | $8.53 | $102.3K | Form 4 |
| Hemrajani Rekha | director | Jun 13, 2024 | AWARD | 20,200 | $8.44 | $170.5K | Form 4 |
| Garland J. Scott | director | Jun 13, 2024 | AWARD | 20,200 | $8.44 | $170.5K | Form 4 |
| GOODMAN COREY S | director, 10 percent owner: | Jun 13, 2024 | AWARD | 20,200 | $8.44 | $170.5K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Jun 4, 2024 | OPTION EX. | 20,000 | $0.99 | $19.8K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Jun 4, 2024 | SELL | 20,000 | $8.43 | $168.7K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Jun 4, 2024 | OPTION EX. | 20,000 | $0.99 | $19.8K | Form 4 |
| Randolph Sophia | director, officer: CHIEF MEDICAL OFFICER | May 13, 2024 | SELL | 10,203 | $15.82 | $161.4K | Form 4 |
| Randolph Sophia | director, officer: CHIEF MEDICAL OFFICER | May 13, 2024 | SELL | 1,797 | $16.67 | $30.0K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | May 6, 2024 | OPTION EX. | 20,000 | $0.99 | $19.8K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | May 6, 2024 | SELL | 20,000 | $15.92 | $318.3K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | May 6, 2024 | OPTION EX. | 20,000 | $0.99 | $19.8K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Apr 16, 2024 | OPTION EX. | 25,846 | $0.99 | $25.6K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Apr 16, 2024 | SELL | 50,000 | $14.20 | $710.2K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Apr 16, 2024 | OPTION EX. | 25,846 | $0.99 | $25.6K | Form 4 |
| Pons Jaume | director, officer: PRESIDENT & CSO | Apr 4, 2024 | SELL | 20,000 | $11.15 | $223.0K | Form 4 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | Mar 14, 2024 | BUY | 4,400 | $11.31 | $49.8K | Form 4 |